A common single nucleotide polymorphism in CTLA4 has been linked with susceptibility and outcome in autoimmune and infectious diseases, respectively. Here, we show that this polymorphism is associated with the frequency of CD4 + CD25 + regulatory T cells in healthy human volunteers. We further show that, on a per cell basis, such regulatory T cells appear to be functionally indistinguishable across CTLA4 genotypes. These data implicate CTLA4 in regulatory T cell development, and provide a mechanism to account for the link between polymorphisms at this locus and the biological outcome of adaptive immune responses to self and to pathogens.
IntroductionInhibition is as important as activation in regulating the vigor of immune responses. Among a variety of inhibitory pathways, attention has focused on CTLA-4, an immunoglobulin superfamily member that plays a key role in restraining T cell responses [1, 2]. Common single nucleotide polymorphisms (SNP) in CTLA4 have been associated with disease susceptibility and outcome in autoimmune diseases and viral hepatitis, respectively [3][4][5]. CTLA4 alleles associated with increased susceptibility to autoimmune disease are also associated with increased clearance of hepatitis B virus infection; similarly alleles associated with protection from autoimmune disease are also associated with reduced clearance of hepatitis B virus infection [4, 5]. Such associations have biological plausibility: decreasing the vigor of T cell responses would be expected to decrease susceptibility to tissue-destructive autoimmune processes as well as to decrease the likelihood of clearing viral infection.The field of immune regulation has been revolutionized by the recent identification of a specialized population of suppressor CD4 + T cells [6, 7]. Characterized phenotypically by constitutive expression of IL-2Ra (CD25), these cells were first identified by their role in maintaining self tolerance. Subsequently, CD4 + CD25 + T cells (Treg) have also been shown to play a central role in restraining the vigor of immune responses to pathogens [8][9][10][11][12][13][14][15]. While CTLA-4 was classically thought to restrain T cell responses by acting in cis on activated T cells [1], it has become clear that CTLA-4 can also act in trans [16,17]. Notably, Treg constitutively express CTLA-4, and Treg-mediated inhibition of T cell responses is due to CTLA-4 in a variety of experimental systems [6, 7,[18][19][20][21][22][23]. In addition to being part of the effector armamentarium of Treg, however, data from mouse models are compatible with a role for CTLA-4 in Treg development [23,24]. We thus hypothesized an influence of CTLA4 polymorphisms on Treg development. (Fig. 1a).No such correlation of genotype and Treg frequency was found for another well-characterized polymorphism (+49; exon 1) in CTLA4 (Fig. 1b). Of interest, this latter polymorphism is in linkage disequilibrium with the CT60 SNP. All volunteers homozygous for the A allele at CT60 were also homozygous for the A allele at +49, but the reverse ...